| P50 | author | Alan Ducatman | Q42788938 |
| P2093 | author name string | Jie Xiao | |
| | Anoop Shankar | |
| P2860 | cites work | Depuration kinetics and tissue disposition of PFOA and PFOS in white leghorn chickens (Gallus gallus) administered by subcutaneous implantation | Q46898224 |
| | Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers | Q46901755 |
| | Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. | Q51555214 |
| | Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers | Q80554158 |
| | Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate | Q80785516 |
| | Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure | Q22306384 |
| | Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability | Q23924062 |
| | Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population | Q24633846 |
| | The C8 health project: design, methods, and participants | Q24652791 |
| | Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000 | Q24680576 |
| | Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program | Q28285436 |
| | K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification | Q29547560 |
| | Prevalence of chronic kidney disease in the United States | Q29614191 |
| | Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA. | Q33702676 |
| | Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi | Q34272627 |
| | The toxicology of perfluorooctanoate | Q34343282 |
| | Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate | Q34557258 |
| | Perfluoroalkyl acids: a review of monitoring and toxicological findings | Q34630884 |
| | Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers | Q34680365 |
| | Microvascular endothelial injury and dysfunction during ischemic acute renal failure. | Q34952527 |
| | Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. | Q35008916 |
| | Elevated uric acid increases the risk for kidney disease | Q36985796 |
| | Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults | Q37139485 |
| | Alteration of microvascular permeability in acute kidney injury | Q37304519 |
| | The metabolic syndrome and chronic kidney disease in U.S. adults | Q38941738 |
| | The association between serum uric acid level and long-term incidence of hypertension: Population-based cohort study | Q39770827 |
| | The relationship between albuminuria and hypercholesterolemia. | Q40461554 |
| | Alterations in cell membrane properties caused by perfluorinated compounds | Q40643223 |
| | Injury of the renal microvascular endothelium alters barrier function after ischemia | Q42439443 |
| | Insulin resistance and risk of chronic kidney disease in nondiabetic US adults | Q44285460 |
| | Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys | Q45095021 |
| | Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis | Q46460012 |
| | Subcellular distribution and protein binding of perfluorooctanoic acid in rat liver and kidney | Q46467482 |
| | Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). | Q46480414 |
| | Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004. | Q46883348 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 893-900 | |
| P577 | publication date | 2011-08-26 | |
| P1433 | published in | American Journal of Epidemiology | Q4744243 |
| P1476 | title | Perfluoroalkyl chemicals and chronic kidney disease in US adults | |
| P478 | volume | 174 | |